Part 1 - Welcome - Dr. Arun Kumar Goel
Part 2 - Session 1 - CDK 4/6 Inhibitors in breast cancer: will they have a Large role in future?
Part 3 - Session 2 - HER2 Targeted Therapy in Breast Cancer : Integrating newer options
Part 4 - Session 3 - Triple Negative Breast Cancer : Moving ahead